STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] MASIMO CORP SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Masimo Corporation (MASI) insider sale notice: This Form 144 shows that 25,061 shares of Masimo common stock are proposed to be sold via Charles Schwab & Co., Inc. on 09/29/2025 with an aggregate market value of $3,553,637. The shares were acquired and paid on 09/29/2025 through an employee stock option exercise using a broker cashless exercise. The filing reports total shares outstanding of 54,324,812. The seller, identified in prior sales as Bilal Muhsin, sold 25,000 shares on 09/23/2025 for $3,518,983 and 50,000 shares on 09/26/2025 for $7,093,910. By combining the prior sales and the proposed sale, the filing documents insider dispositions totaling 100,061 shares during late September 2025. The filer certifies no undisclosed material adverse information and includes the standard Rule 144 representations.

Positive
  • Transaction mechanics disclosed: The filing clearly states acquisition via an employee stock option exercise and payment method (broker cashless exercise), improving transparency.
  • Full disclosure of recent sales: Prior sales on 09/23/2025 and 09/26/2025 are reported with gross proceeds, providing clear historical context.
Negative
  • Large insider selling: Insider dispositions total 100,061 shares in late September 2025, which may increase share supply and affect market perception.
  • Concentrated timing: Multiple sizable sales occurred within a one-week window (09/23–09/29/2025), which could raise investor concern about insider confidence.

Insights

TL;DR: Insider disposed of a meaningful block of MASI shares across late September, which could increase short-term supply pressure.

The filing documents a planned sale of 25,061 shares on 09/29/2025 and two recent sales totaling 75,000 shares earlier that week, bringing insider dispositions to 100,061 shares. The shares were acquired via an employee option exercise and the sale will be executed through Charles Schwab, indicating routine execution mechanics rather than private placement. From a trading-impact perspective, cumulative insider sales of this size relative to 54.3 million shares outstanding represent a non-trivial increase in available float over a short period. This is a factual disclosure of insider selling; it does not by itself indicate company performance but is relevant to supply/demand dynamics and investor sentiment.

TL;DR: Multiple insider sales reported under Rule 144 suggest personal liquidity actions; disclosure appears complete under Rule 144 mechanics.

The notice shows securities acquired and paid on 09/29/2025 via employee stock option exercise with a cashless broker payment, then proposed for sale the same day. Prior sales by the same individual on 09/23/2025 and 09/26/2025 are disclosed with gross proceeds. The filing includes the required representation that the seller is unaware of undisclosed material adverse information and the standard Rule 144 attestations. From a governance standpoint, the document meets procedural requirements; the clustered timing of sales may prompt investor questions about insider motives, but no governance violations or undisclosed facts are evident in the filing itself.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the MASI Form 144 filed for 09/29/2025 disclose?

The filing discloses a proposed sale of 25,061 Masimo (MASI) shares on 09/29/2025 through Charles Schwab with an aggregate market value of $3,553,637.

Who sold shares of MASI in the recent Form 144 filings?

The seller associated with the past sales is named as Bilal Muhsin and the current Form 144 shows the proposed sale for the account of the person who exercised employee options.

How many MASI shares were sold in the three transactions disclosed in late September 2025?

The filing shows sales of 25,000 shares on 09/23/2025, 50,000 shares on 09/26/2025, and a proposed 25,061 shares on 09/29/2025, totaling 100,061 shares.

How were the 25,061 shares acquired before the planned sale?

They were acquired on 09/29/2025 via an employee stock option exercise from Masimo Corporation and the exercise used a broker cashless payment.

What is the number of Masimo shares outstanding reported in the filing?

The filing lists 54,324,812 shares outstanding.
Masimo Corp

NASDAQ:MASI

MASI Rankings

MASI Latest News

MASI Latest SEC Filings

MASI Stock Data

7.73B
50.67M
5.97%
107.16%
6.51%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
IRVINE